Role of CDK8 and β-catenin in colorectal adenocarcinoma

Oncology Reports

Volumn 24, Issue 1, 2010, Pages 285-291

  Seo, Jong Og ^a   Han, Song Iy ^a   Lim, Sung Chul ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

catenin; Adenocarcinoma; CDK8; Colon; Rectum

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE 8; CDK8 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CARCINOGENESIS; CELL STRAIN HCT116; COLON CANCER; COLORECTAL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; TUMOR GROWTH; WESTERN BLOTTING; ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; DRUG SCREENING; HCT116 CELL LINE; HT 29 CELL LINE; METABOLISM; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL; TUMOR CELL CULTURE;

ADENOCARCINOMA; BETA CATENIN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE 8; DRUG EVALUATION, PRECLINICAL; FEMALE; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; PROGNOSIS; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 77952977350     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000858     Document Type: Article

References (25)

1. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I and Kerr D: Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499, 2009.
2. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237, 1992.
3. Firestein R and Hahn WC: Revving the throttle on an oncogene: CDK8 takes the driver seat. Cancer Res 15: 7899-7901, 2009.
4. Oving IM and Clevers HC: Molecular causes of colon cancer. Eur J Clin Invest 32: 448-457, 2002.
5. Kim S, Xu X, Hecht A and Boyer TG: Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem 281: 14066-14075, 2006.
6. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M and Hahn WC: CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455: 547-551, 2008.
7. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Naar AM and Dyson NJ: E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455: 552-556, 2008.
8. Greene FL, Page DL and Fleming ID: AJCC Cancer Staging Manual, 6th edition. Springer-Verlag, New York, 2002.
9. Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Kirkner GJ, Dehari R, Meyerhardt JA, Fuchs CS and Ogino S: Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. Neoplasia 9: 569-577, 2007. (Pubitemid 47121831)
10. Firestein R, Shima K, Nosho K, Irahara N, Baba Y, Bojarski E, Giovannucci EL, Fuchs CS and Ogino S: CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int J Cancer 126: 2863-2873, 2010.
11. Brattain MG, Fine WD, Khaled FM, Thompson J and Brattain DE: Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res 41: 1751-1756, 1981. (Pubitemid 11114567)
12. Fogh J (ed): Human Tumor Cells in vitro. Plenum Press, New York, pp115-159, 1975.
13. Park JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE and Gazdar A: Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 15: 6710-6718, 1987. (Pubitemid 18019675)
14. Clevers H: Wnt breakers in colon cancer. Cancer Cell 5: 5-6, 2004.
15. Attisano L and Labbe E: TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 23: 53-61, 2004.
16. Buchanan FG and DuBois RN: Connecting COX-2 and Wnt in cancer. Cancer Cell 9: 6-8, 2006.
17. Castellone MD, Teramoto H, Williams BO, Druey KM and Gutkind JS: Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310: 1504-1510, 2005.
18. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K and Harris CC: Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63: 728-734, 2003. (Pubitemid 36158154)
19. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK and Albertsen H: APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5: 165-170, 2007. (Pubitemid 46423997)
20. Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, Sood A, Malhotra V, Sood N, Midda V and Monga DK: Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8: 279-289, 2006.
21. Thorstensen L, Lind GE, Lovig T, Diep CB, Meling GI, Rognum TO and Lothe RA: Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability. Neoplasia 7: 99-108, 2005. (Pubitemid 40315987)
22. Casamassimi A and Napoli C: Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 89: 1439 - 1946, 2007.
23. Gold MO and Rice AP: Targeting of CDK8 to a promoterproximal RNA element demonstrates catalysis dependent activation of gene expression. Nucleic Acids Res 26: 3784-3788, 1998.
24. Fryer CJ, White JB and Jones KA: Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16: 509-520, 2004.
25. Donner AJ, Szostek S, Hoover JM and Espinosa JM: CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 27: 121-133, 2007. (Pubitemid 46991381)